Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Overstock Announces Canadian Broker-Dealer Echelon Can Now Trade Digital Preferred Shares, OSTKO
Overstock.com, Inc.January 12, 2021 GMT
SALT LAKE CITY, Jan. 12, 2021 (GLOBE NEWSWIRE) Overstock.com, Inc. (NASDAQ:OSTK), a leading e-commerce home furnishing retailer and advocate of blockchain technology, announced today that Canadian customers of Echelon Wealth Partners Inc. (Echelon), an independent, Canadian-owned and operated wealth management and capital markets firm, can now trade Overstock’s Series A-1 shares (OSTKO) on the alternative trading system (ATS) operated by tZERO ATS, LLC, a FINRA member broker-dealer. This is possible through broker arrangements with an existing subscriber to the ATS. In May 2020, Overstock distributed Series A-1 shares as a dividend to Overstock shareholders.
Press release content from Newswire. The AP news staff was not involved in its creation.
Cedar Honored by Built In in Its Esteemed 2021 Best Places to Work Awards
January 11, 2021 GMT
Cedar Honored by Built In in Its Esteemed 2021 Best Places to Work Awards
NEW YORK - January 11, 2021 - ( Newswire.com )
ADVERTISEMENT
Founded in 2016, Cedar is a healthcare financial engagement platform for hospitals, health systems and medical groups that clarifies and simplifies the financial experience for patients, improving bill resolution and payment outcomes for providers. Using intuitive design and advanced data science, Cedar facilitates patient-centric financial engagement across the care journey.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
DIACCURATE acquires BIOKINESIS to create a sole-in-class biotech player in oncology and .
DIACCURATEJanuary 12, 2021 GMT
Dr. Dominique BRIDON leads the new entity
DIACCURATE is now developing 3 programs in cancer and immunotherapy
DIACCURATE will be initiating a first clinical trial by early 2022
Paris, France, January 12, 2021
By acquiring BIOKINESIS, a French biotech that develops the very first anticancer compound targeting the Golgi apparatus, DIACCURATE comforts its “sole-in-class” therapeutic strategy in oncology and immunotherapy. The company is developing a new generation of drug candidates which relies on novel mechanisms of action and untapped cellular and subcellular compartments. Initial data already suggest that this highly innovative approach could help to improve resitance to cancer progression and extend the benefits of immunotherapy to more indications and pati
Press release content from Accesswire. The AP news staff was not involved in its creation.
Emgold Expands Its Flagship Golden Arrow Property, NV
January 12, 2021 GMT
VANCOUVER, BC / ACCESSWIRE / January 12, 2021 / Emgold Mining Corporation (TSXV:EMR) (“Emgold” or the “Company”) is pleased to announce it has staked an additional 137 unpatented mining claims at its Golden Arrow Property, NV (the “Property”). This increases the Property size to 17 patented claims and 494 unpatented claims controlled by the Company, or about 10,000 acres (4,050 hectares) in total area. The new claims extend the current property to the south covering an area of historic mine workings.
About the Golden Arrow Property